Home/ Stocks/ COEP

Coeptis Therapeutics Holdings Inc. Common Stock

COEP XNAS

$10.40 -1.11 (-10.04%) ▼ 15-min delayed

Open

$11.06

High

$11.06

Low

$9.78

Volume

68.1K

Market Cap

$68.83M

About Coeptis Therapeutics Holdings Inc. Common Stock

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Sector: FINANCE SERVICES Employees: 6 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$1.36M	$-12,277,192	$-2.81
FY 2025	$1.36M	$-12,277,192	$-2.81
Q3 2025	$237.4K	$-2,739,403	$-0.58
Q2 2025	$200.7K	$-4,334,586	$-1.17

Related Market News

No specific coverage for COEP yet. Check out our latest market news or earnings calendar.

Get COEP Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Coeptis Therapeutics Holdings Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.